1. Hesketh PJ, Murphy WK, Lester EP, et al. GR 38032F (GR-C507/ 75): a novel compound effective in the prevention of acute cis- platin-induced emesis.J Clin Oncol. 1989;7:700–705.
2. Marty M. A comparative study of the use of granisetron, a selective 5-HT3 antagonist, versus a standard anti-emetic regimen of chlor- promazine plus dexamethasone in the treatment of cytostatic- induced emesis: the Granisetron Study Group.Eur J Cancer. 1990; 26(suppl 1):S28-S32.
3. Navari RM, Kaplan HG, Gralla RJ, et al. Efficacy and safety of granisetron, a selective 5-hydroxytryptamine-3 receptor antagonist, in the prevention of nausea and vomiting induced by high- dose cisplatin.J Clin Oncol. 1994;12:2204–2210.
4. Hunter AE, Prentice HG, Pothecary K, et al. Granisetron, a selective 5-HT3 receptor antagonist, for the prevention of radiation induced emesis during total body irradiation.Bone Marrow Transplant. 1991;7:439–441.
5. Okamoto S, Takahashi S, Tanosaki R, et al. Granisetron in the prevention of vomiting induced by conditioning for stem cell transplantation: a prospective randomized study.Bone Marrow Transplant. 1996;17:679–683.